Skip to main content
Erschienen in: European Radiology 7/2019

23.04.2019 | Oncology

Actual frequency of imaging during follow-up of testicular cancer in Israel—a comparison with the guidelines

verfasst von: Anna-Therese Lehnich, Carsten Rusner, Gabriel Chodick, Rachel Katz, Tal Sella, Andreas Stang

Erschienen in: European Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Computed tomography (CT) examinations are frequent in follow-up care of testicular cancer (TC) but may increase the risk for other cancers. We wanted to assess the actual number of CT and X-ray examinations within the first 5 years after a diagnosis of TC in Israel during 2003–2007.

Methods

The database of Maccabi Healthcare Services, Israel, was searched for TC patients diagnosed in 2003 to 2007 by direct linkage with the Israel National Cancer Registry. Data on diagnostic imaging examinations (CT of chest, abdomen, or pelvis, unspecified sites; X-ray of chest) were extracted during a 5-year follow-up for 226 incident patients. The actual number of CT and X-ray examinations was compared to the National Comprehensive Cancer Network (NCCN) guideline. We tabulated the median with 10th and 90th percentiles (P10, P90) for the number of CTs and X-rays considering histology, stage, and adjuvant strategy.

Results

The number of abdomen or pelvis CTs for TC patients receiving chemo- or radiotherapy was in accordance with the NCCN guideline. The median of abdomen or pelvis CTs for surveillance patients was 8.5 (P10, P90: 3; 13) for nonseminoma and 5.0 (P10, P90: 5; 13) for seminoma patients compared to 14 to 17 CTs recommended. The number of chest X-rays was lower than recommended in the guideline for all adjuvant strategies.

Conclusions

The NCCN guidelines regarding CTs were met for TC patients treated with chemo- or radiotherapy but fell below recommendations for surveillance. Guidelines from 2011 and 2012 were updated in favor of fewer CTs during surveillance.

Key Points

• The number of CTs followed the NCCN guidelines in patients treated with chemo- or radiotherapy.
• Surveillance patients received fewer CTs and X-rays than recommended in the NCCN guidelines from 2005.
• The number of applied CT examinations corresponded to a radiation dose that did not substantially raise the lifetime risk for cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Beri A, Matzkin H, Liphshitz I, Barchana M (2007) Epidemiological characteristics and trends of testicular cancer in Israel 1992–2002. Harefuah 146:515–519,575PubMed Beri A, Matzkin H, Liphshitz I, Barchana M (2007) Epidemiological characteristics and trends of testicular cancer in Israel 1992–2002. Harefuah 146:515–519,575PubMed
2.
Zurück zum Zitat Znaor A, Lortet-Tieulent J, Jemal A, Bray F (2014) International variations and trends in testicular cancer incidence and mortality. Eur Urol 65:1095–1106CrossRefPubMed Znaor A, Lortet-Tieulent J, Jemal A, Bray F (2014) International variations and trends in testicular cancer incidence and mortality. Eur Urol 65:1095–1106CrossRefPubMed
3.
Zurück zum Zitat Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA (2015) International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007. Andrology 3:4–12CrossRefPubMed Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA (2015) International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973–2007. Andrology 3:4–12CrossRefPubMed
4.
Zurück zum Zitat Daugaard G, Gundgaard MG, Mortensen MS et al (2014) Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol 32:3817–3823CrossRefPubMed Daugaard G, Gundgaard MG, Mortensen MS et al (2014) Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol 32:3817–3823CrossRefPubMed
5.
Zurück zum Zitat Verhoeven RHA, Karim-Kos HE, Coebergh JWW et al (2014) Markedly increased incidence and improved survival of testicular cancer in the Netherlands. Acta Oncol 53:342–350CrossRefPubMed Verhoeven RHA, Karim-Kos HE, Coebergh JWW et al (2014) Markedly increased incidence and improved survival of testicular cancer in the Netherlands. Acta Oncol 53:342–350CrossRefPubMed
6.
Zurück zum Zitat Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377–1399CrossRefPubMed Schmoll HJ, Souchon R, Krege S et al (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377–1399CrossRefPubMed
7.
Zurück zum Zitat Motzer RJ, Bahnson RR, Boston B et al (2005) Testicular cancer. clinical practice guidelines. J Natl Compr Canc Netw 3:52–76PubMed Motzer RJ, Bahnson RR, Boston B et al (2005) Testicular cancer. clinical practice guidelines. J Natl Compr Canc Netw 3:52–76PubMed
8.
Zurück zum Zitat Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol 53:478–496CrossRefPubMed Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol 53:478–496CrossRefPubMed
9.
Zurück zum Zitat Nichols CR, Roth B, Albers P et al (2013) Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 31:3490–3493CrossRefPubMed Nichols CR, Roth B, Albers P et al (2013) Active surveillance is the preferred approach to clinical stage I testicular cancer. J Clin Oncol 31:3490–3493CrossRefPubMed
10.
Zurück zum Zitat Brenner DJ, Hall EJ (2007) Computed tomography - an increasing source of radiation exposure. N Engl J Med 357:2277–2284CrossRefPubMed Brenner DJ, Hall EJ (2007) Computed tomography - an increasing source of radiation exposure. N Engl J Med 357:2277–2284CrossRefPubMed
11.
Zurück zum Zitat Pearce MS, Salotti JA, Howe NL et al (2012) CT scans in young people in Great Britain: temporal and descriptive patterns, 1993–2002. Radiol Res Pract 2012:594278PubMedPubMedCentral Pearce MS, Salotti JA, Howe NL et al (2012) CT scans in young people in Great Britain: temporal and descriptive patterns, 1993–2002. Radiol Res Pract 2012:594278PubMedPubMedCentral
12.
Zurück zum Zitat Mathews JD, Forsythe AV, Brady Z et al (2013) Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346:f2360CrossRefPubMedPubMedCentral Mathews JD, Forsythe AV, Brady Z et al (2013) Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346:f2360CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Miglioretti DL, Johnson E, Williams A et al (2013) The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–707CrossRefPubMedPubMedCentral Miglioretti DL, Johnson E, Williams A et al (2013) The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:700–707CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086CrossRefPubMedPubMedCentral Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Tarin TV, Sonn G, Shinghal R (2009) Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181:627–632CrossRefPubMed Tarin TV, Sonn G, Shinghal R (2009) Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181:627–632CrossRefPubMed
16.
Zurück zum Zitat Krege S, Souchon R, Schmoll HJ, German Testicular Cancer Study Group (2001) Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol 40:372–391CrossRefPubMed Krege S, Souchon R, Schmoll HJ, German Testicular Cancer Study Group (2001) Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol 40:372–391CrossRefPubMed
17.
Zurück zum Zitat Bradford TJ, Montie JE, Hafez KS (2006) The role of imaging in the surveillance of urologic malignancies. Urol Clin North Am 33:377–396CrossRefPubMed Bradford TJ, Montie JE, Hafez KS (2006) The role of imaging in the surveillance of urologic malignancies. Urol Clin North Am 33:377–396CrossRefPubMed
18.
Zurück zum Zitat van As NJ, Gilbert DC, Money-Kyrle J et al (2008) Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer 98:1894–1902CrossRefPubMedPubMedCentral van As NJ, Gilbert DC, Money-Kyrle J et al (2008) Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer 98:1894–1902CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat van Walraven C, Fergusson D, Earle C et al (2011) Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol 29:2883–2888CrossRefPubMed van Walraven C, Fergusson D, Earle C et al (2011) Association of diagnostic radiation exposure and second abdominal-pelvic malignancies after testicular cancer. J Clin Oncol 29:2883–2888CrossRefPubMed
20.
Zurück zum Zitat Rusner C, Stang A, Dieckmann KP, Friedel H (2013) Frequency of computed tomography examinations in the follow-up care of testicular cancer patients – an evaluation of patterns of care in Germany. Onkologie 36:188–192CrossRefPubMed Rusner C, Stang A, Dieckmann KP, Friedel H (2013) Frequency of computed tomography examinations in the follow-up care of testicular cancer patients – an evaluation of patterns of care in Germany. Onkologie 36:188–192CrossRefPubMed
21.
Zurück zum Zitat Israel Ministry of Health (2010) Israel Center for Disease Control Health status in Israel 2010. Israel Ministry of Health, Tel-Hashomer Israel Ministry of Health (2010) Israel Center for Disease Control Health status in Israel 2010. Israel Ministry of Health, Tel-Hashomer
23.
Zurück zum Zitat Young JL, Roffers SD, Gloeckler Ries LA, Fritz AG, Hurlbut AA (2000) SEER summary staging manual 2000. SEER Program, US National Cancer Institute, Bethesda Young JL, Roffers SD, Gloeckler Ries LA, Fritz AG, Hurlbut AA (2000) SEER summary staging manual 2000. SEER Program, US National Cancer Institute, Bethesda
24.
Zurück zum Zitat Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2:269–279CrossRefPubMed Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2:269–279CrossRefPubMed
26.
Zurück zum Zitat Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Board on Radiation Effects, Research Division on Earth and Life Studies, National Research Council of the National Academies (2006) Health risks from exposure to low levels of ionizing radiation: BEIR VII, phase 2. National Acad. Press, Washington, D.C. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Board on Radiation Effects, Research Division on Earth and Life Studies, National Research Council of the National Academies (2006) Health risks from exposure to low levels of ionizing radiation: BEIR VII, phase 2. National Acad. Press, Washington, D.C.
27.
Zurück zum Zitat Sodickson A, Baeyens PF, Andriole KP et al (2009) Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 251:175–184CrossRefPubMed Sodickson A, Baeyens PF, Andriole KP et al (2009) Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 251:175–184CrossRefPubMed
28.
Zurück zum Zitat Grunau GL, Gueron S, Pornov B, Linn S (2018) The risk of cancer might be lower than we think. Alternatives to lifetime risk estimates. Rambam Maimonides Med J 9(e0002):1–10 Grunau GL, Gueron S, Pornov B, Linn S (2018) The risk of cancer might be lower than we think. Alternatives to lifetime risk estimates. Rambam Maimonides Med J 9(e0002):1–10
29.
Zurück zum Zitat Sullivan CJ, Murphy KP, McLaughlin PD et al (2015) Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur Radiol 25:1005–1013CrossRefPubMed Sullivan CJ, Murphy KP, McLaughlin PD et al (2015) Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur Radiol 25:1005–1013CrossRefPubMed
30.
Zurück zum Zitat Grimison P, Houghton B, Chatfield M et al (2013) Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU Int 112:E35–E43CrossRefPubMed Grimison P, Houghton B, Chatfield M et al (2013) Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU Int 112:E35–E43CrossRefPubMed
31.
Zurück zum Zitat Su D, Faiena I, Tokarz R, Bramwit M, Weiss RE (2015) Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early stage nonseminomatous germ cell tumors. Urology 85:141–146CrossRefPubMed Su D, Faiena I, Tokarz R, Bramwit M, Weiss RE (2015) Comparative analysis of the risk of radiation exposure and cost of reduced imaging intensity for surveillance of early stage nonseminomatous germ cell tumors. Urology 85:141–146CrossRefPubMed
32.
Zurück zum Zitat Motzer RJ, Agarwal N, Beard C et al (2012) Testicular cancer. clinical practice guidelines. J Natl Compr Canc Netw 10:502–535CrossRefPubMed Motzer RJ, Agarwal N, Beard C et al (2012) Testicular cancer. clinical practice guidelines. J Natl Compr Canc Netw 10:502–535CrossRefPubMed
33.
Zurück zum Zitat Zinsser D, Marcus R, Othman AE et al (2018) Dose reduction and dose management in computed tomography – state of the art. Rofo 190:531–541CrossRefPubMed Zinsser D, Marcus R, Othman AE et al (2018) Dose reduction and dose management in computed tomography – state of the art. Rofo 190:531–541CrossRefPubMed
34.
Zurück zum Zitat Kleinke AM, Classen CF (2018) Adolescents and young adults with cancer: aspects of adherence - a questionnaire study. Adolesc Health Med Ther 9:77–85CrossRefPubMedPubMedCentral Kleinke AM, Classen CF (2018) Adolescents and young adults with cancer: aspects of adherence - a questionnaire study. Adolesc Health Med Ther 9:77–85CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat McGrady ME, Brown GA, Pai AL (2016) Medication adherence decision-making among adolescents and young adults with cancer. Eur J Oncol Nurs 20:207–214CrossRefPubMed McGrady ME, Brown GA, Pai AL (2016) Medication adherence decision-making among adolescents and young adults with cancer. Eur J Oncol Nurs 20:207–214CrossRefPubMed
36.
Zurück zum Zitat Smits-Seemann RR, Kaul S, Zamora ER, Wu YP, Kirchhoff AC (2017) Barriers to follow-up care among survivors of adolescent and young adult cancer. J Cancer Surviv 11:126–132CrossRefPubMed Smits-Seemann RR, Kaul S, Zamora ER, Wu YP, Kirchhoff AC (2017) Barriers to follow-up care among survivors of adolescent and young adult cancer. J Cancer Surviv 11:126–132CrossRefPubMed
37.
Zurück zum Zitat Oliver RTD, Mason MD, Mead GM et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293–300CrossRefPubMed Oliver RTD, Mason MD, Mead GM et al (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366:293–300CrossRefPubMed
38.
Zurück zum Zitat Barrisford GW, Kreydin EI, Preston MA, Rodriguez D, Harisighani MG, Feldman AS (2015) Role of imaging in testicular cancer: current and future practice. Future Oncol 11:2575–2586CrossRefPubMed Barrisford GW, Kreydin EI, Preston MA, Rodriguez D, Harisighani MG, Feldman AS (2015) Role of imaging in testicular cancer: current and future practice. Future Oncol 11:2575–2586CrossRefPubMed
39.
Zurück zum Zitat Kok HK, Leong S, Torregiani WC (2014) Is magnetic resonance imaging comparable with computed tomography in the diagnosis of retroperitoneal metastasis in patients with testicular cancer? Can Assoc Radiol J 65:196–198CrossRefPubMed Kok HK, Leong S, Torregiani WC (2014) Is magnetic resonance imaging comparable with computed tomography in the diagnosis of retroperitoneal metastasis in patients with testicular cancer? Can Assoc Radiol J 65:196–198CrossRefPubMed
41.
Zurück zum Zitat Nestler T, Baunacke M, Dräger D, Landenberg N, Groeben C, Huber J (2019) Testicular cancer guideline adherence and patterns of care in Germany: a nationwide survey. Eur J Cancer Care 28:e12917CrossRef Nestler T, Baunacke M, Dräger D, Landenberg N, Groeben C, Huber J (2019) Testicular cancer guideline adherence and patterns of care in Germany: a nationwide survey. Eur J Cancer Care 28:e12917CrossRef
42.
Zurück zum Zitat De La Pena H, Sharma A, Glicksman C et al (2017) No longer any role for routine follow-up chest X-rays in men with stage I germ cell cancer. Eur J Cancer 84:354–359CrossRef De La Pena H, Sharma A, Glicksman C et al (2017) No longer any role for routine follow-up chest X-rays in men with stage I germ cell cancer. Eur J Cancer 84:354–359CrossRef
43.
Zurück zum Zitat Travis LB, Fossa SD, Schonfeld SJ et al (2005) Second cancers among 40 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354–1365CrossRefPubMed Travis LB, Fossa SD, Schonfeld SJ et al (2005) Second cancers among 40 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97:1354–1365CrossRefPubMed
44.
Zurück zum Zitat Curreri SA, Fung C, Beard CJ (2015) Secondary malignant neoplasms in testicular cancer survivors. Urol Oncol 33:392–398CrossRefPubMed Curreri SA, Fung C, Beard CJ (2015) Secondary malignant neoplasms in testicular cancer survivors. Urol Oncol 33:392–398CrossRefPubMed
Metadaten
Titel
Actual frequency of imaging during follow-up of testicular cancer in Israel—a comparison with the guidelines
verfasst von
Anna-Therese Lehnich
Carsten Rusner
Gabriel Chodick
Rachel Katz
Tal Sella
Andreas Stang
Publikationsdatum
23.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06148-1

Weitere Artikel der Ausgabe 7/2019

European Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.